Y10S 530/854
Glands
Y10S530/854 (Glands) appears on 61 US grants and 7 published applications in this corpus.
Search patents in Y10S- Granted patents
- 61
- Published applications
- 7
- Assignees
- 37
- Inventors
- 85
- Latest grant
- 22 Jun 2010
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 3 | 0 |
| 1978 | 3 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 5 | 0 |
| 1984 | 1 | 0 |
| 1985 | 5 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 4 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 4 | 0 |
| 1995 | 1 | 0 |
| 1996 | 5 | 0 |
| 1997 | 3 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 3 |
| 2003 | 3 | 2 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Prostatic growth factor22 Jun 2010US 7,741,055 B2Human Genome Sciences, Inc.
- Therapeutic use of the SMR1 protein and active derivatives thereof30 Sep 2008US 7,429,448 B2Institut Pasteur
- Prostatic growth factor16 Oct 2007US 7,282,351 B2Human Genome Sciences, Inc.
- Therapeutic use of the SMR1 protein and active derivatives thereof16 Nov 2004US 6,818,405 B2Institut Pasteur
- Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives8 Jul 2003US 6,589,750 B2Institut Pasteur
- Prostatic Growth Factor19 Jul 2007US 2007/0166310 A1Human Genome Sciences, Inc.
- Therapeutic use of the SMR1 protein and active derivatives thereof11 Mar 2004US 2004/0047805 A1Institut Pasteur
- Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives16 Oct 2003US 2003/0195155 A1Institut Pasteur
- Prostatic growth factor27 Mar 2003US 2003/0059431 A1Human Genome Sciences, Inc.
- Therapeutic use of the smr 1 protein and active derivatives thereof26 Dec 2002US 2002/0198361 A1Institut Pasteur
Most cited
By later US patents
- Controlled release formulations of trophic factors in ganglioside-lipsome vehicle653US 5,073,543 AG. D. Searle & Co. · 1991
- Protein purification process and product66US 4,503,035 AHoffmann-La Roche Inc. · 1985
- Stabilized compositions containing epidermal growth factor63US 4,717,717 AEthicon, Inc. · 1988
- Immunoassay of thymosin .alpha..sub.161US 4,427,783 AHoffmann-La Roche Inc. · 1984
- Immunogens against gonadotropin releasing hormone43US 5,688,506 AAphton Corporation · 1997